Codrug: An efficient approach for drug optimization N Das, M Dhanawat, B Dash, RC Nagarwal, SK Shrivastava European Journal of Pharmaceutical Sciences 41 (5), 571-588, 2010 | 147 | 2010 |
Nanocrystal technology in the delivery of poorly soluble drugs: an overview R C Nagarwal, R Kumar, M Dhanawat, N Das, J K Pandit Current drug delivery 8 (4), 398-406, 2011 | 89 | 2011 |
Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development TW Wong, M Dhanawat, MJ Rathbone Expert Opinion on Drug Delivery 11 (9), 1419-1434, 2014 | 76 | 2014 |
An overview on antiepileptic drugs N Das, M Dhanawat, SK Shrivastava Drug discoveries & therapeutics 6 (4), 178-193, 2012 | 69 | 2012 |
In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles R Kumar, RC Nagarwal, M Dhanawat, JK Pandit Journal of biomedical nanotechnology 7 (3), 325-333, 2011 | 69 | 2011 |
Modified PLA nano in situ gel: a potential ophthalmic drug delivery system RC Nagarwal, R Kumar, M Dhanawat, JK Pandit Colloids and Surfaces B: Biointerfaces 86 (1), 28-34, 2011 | 66 | 2011 |
Carbon nanotubes: a potential concept for drug delivery applications R Kumar, M Dhanawat, S Kumar, B N Singh, J K Pandit, V R Sinha Recent patents on drug delivery & formulation 8 (1), 12-26, 2014 | 45 | 2014 |
Textbook of cosmetic formulations G Sharma, J Gadhiya, M Dhanawat Department of Pharmacy, Mewar University, Rajasthan-312 901, 2018 | 44 | 2018 |
Design, synthesis, and anticonvulsant screening of some substituted piperazine and aniline derivatives of 5-phenyl-oxazolidin-2, 4-diones and 5, 5-diphenylimidazolidin-2, 4 diones M Dhanawat, AG Banerjee, SK Shrivastava Medicinal Chemistry Research 21, 2807-2822, 2012 | 41 | 2012 |
Unwinding complexities of diabetic Alzheimer by potent novel molecules S Gupta, A Nair, V Jhawat, N Mustaq, A Sharma, M Dhanawat, SA Khan American Journal of Alzheimer's Disease & Other Dementias® 35, 1533317520937542, 2020 | 25 | 2020 |
Design, synthesis, preliminary pharmacological evaluation, and docking studies of pyrazoline derivatives N Das, B Dash, M Dhanawat, SK Shrivastava Chemical Papers 66, 67-74, 2012 | 25 | 2012 |
Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension M Batra, S Gupta, AB Nair, M Dhanawat, S Sandal, MA Morsy European Journal of Ophthalmology 31 (5), 2237-2244, 2021 | 24 | 2021 |
Bestowal of quinazoline scaffold in anticancer drug discovery R Das, DK Mehta, M Dhanawat Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021 | 24 | 2021 |
Antimalarial drug development: past to present scenario M Dhanawat, N Das, RC Nagarwal, SK Shrivastava Mini Reviews in Medicinal Chemistry 9 (12), 1447-1469, 2009 | 20 | 2009 |
Solid-phase synthesis of oligosaccharide drugs: a review M Dhanawat, SK Shrivastava Mini Reviews in Medicinal Chemistry 9 (2), 169-185, 2009 | 20 | 2009 |
Medicinal plants in cancer treatment: contribution of nuclear factor-kappa B (NF-kB) inhibitors R Das, DK Mehta, M Dhanawat Mini Reviews in Medicinal Chemistry 22 (15), 1938-1962, 2022 | 15 | 2022 |
Pharmacokinetics and tissue distribution of hydrazinocurcumin in rats Satyavert, S Gupta, H Choudhury, S Jacob, AB Nair, M Dhanawat, ... Pharmacological Reports 73, 1734-1743, 2021 | 14 | 2021 |
Design, synthesis, anticonvulsant screening and 5HT1A/2A receptor affinity of N (3)-substituted 2, 4-imidazolidinediones and oxazolidinediones M Dhanawat, N Das, SK Shrivastava Drug Discoveries & Therapeutics 5 (5), 227-237, 2011 | 14 | 2011 |
Naturally inspired pyrimidines analogues for alzheimer’s disease S Singh, M Dhanawat, S Gupta, D Kumar, S Kakkar, A Nair, I Verma, ... Current Neuropharmacology 19 (2), 136-151, 2021 | 12 | 2021 |
Understanding the pathogenesis involved in Parkinson’s disease and potential therapeutic treatment strategies M Dhanawat, DK Mehta, S Gupta, R Das Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2020 | 12 | 2020 |